Interferon Alfa-2b or Not 2b? Significant Differences Exist in the Decision-Making Process between Melanoma Patients Who Accept or Decline High-Dose Adjuvant Interferon Alfa-2b Treatment

✍ Scribed by TRACY B. BRAMLETTE; DAVID H. LAWSON; CARL V. WASHINGTON; EMIR VELEDAR; BARRY R. JOHNS; STACEY F. BRISMAN; LIANA ABRAMOVA; SUEPHY C. CHEN

• Book ID: 109076333
• Publisher: John Wiley and Sons
• Year: 2007
• Tongue: English
• Weight: 181 KB
• Volume: 33
• Category: Article
• ISSN: 1076-0512
• DOI: 10.1111/j.1524-4725.2007.33001.x